Work

Randomized controlled trial of perhexiline on regression of left ventricular hypertrophy in patients with symptomatic hypertrophic cardiomyopathy (RESOLVE-HCM trial)

Year: 2021

Type: article

Study design: Study Protocol

Source: American Heart Journal

DOI: 10.1016/j.ahj.2021.06.010

Authors: Rajiv Ananthakrishna, Sau L Lee, Jonathon Foote, Benedetta C Sallustio, Giulia Binda, Arduino A Mangoni, Richard Woodman, Christopher Semsarian, John D Horowitz, Joseph B Selvanayagam

Institutions: Flinders University, Flinders Medical Centre, South Australian Health and Medical Research Institute, Basil Hetzel Institute, Queen Elizabeth Hospital, The University of Adelaide, The University of Sydney, Royal Prince Alfred Hospital, Centenary Institute

Language: English

Topic: Cardiomyopathy and Myosin Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Heart Foundation of Australia

Award: G2563343622

OpenAlex ID: W3177380331

FWCI: 3.328

Cites: 42

Cited by: 29

Related to: 10